Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer Registry | Zendy

Zin Myint | Zendy; Runa Shrestha | Zendy; Salahuddin Siddiqui | Zendy; Stacey Slone | Zendy; Bin Huang | Zendy; Reshma Ramlal | Zendy; Gregory Monohan | Zendy; Gerhard Hildebrandt | Zendy; Hayder Saeed | Zendy

Open Access

Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer Registry

Author(s) -

Zin Myint,

Runa Shrestha,

Salahuddin Siddiqui,

Stacey Slone,

Bin Huang,

Reshma Ramlal,

Gregory Monohan,

Gerhard Hildebrandt,

Hayder Saeed

Publication year - 2019

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2019.08.009

Subject(s) - stage (stratigraphy) , medicine , cancer registry , hodgkin lymphoma , cancer , oncology , lymphoma , classical hodgkin lymphoma , biology , paleontology

Early stage classical Hodgkin lymphoma (cHL) has an excellent outcome. Recent studies focus on decreasing toxicity related to the addition of radiation along with chemotherapy. Real-life reporting of the addition of radiation to chemotherapy is lacking. This study investigates the outcomes obtained from a statewide cancer registry for early stage cHL patients treated with chemotherapy alone (CT) versus patients treated with the combined modality of chemotherapy and radiation (CMT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research